TickerFactsScreenerDevelopers

Serina Therapeutics, Inc. (SER) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$6.29M2018: -$8.00M2019: -$10.16M2020: -$7.82M2021: -$7.86M2022: -$5.94M2023: -$2.48M2024: -$17.14M2025: -$17.95M-$17.95M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$17.95M-4.8%
2024-$17.14M-592.1%
2023-$2.48M+58.3%
2022-$5.94M+24.4%
2021-$7.86M-0.5%
2020-$7.82M+23.1%
2019-$10.16M-27.1%
2018-$8.00M-27.2%
2017-$6.29M—